ruthenium has been researched along with naphthoquinones in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Bharathi, A; Polasa, H | 1 |
| Chia, S; Dunn, B; Franville, AC; Hernandez, R; Minoofar, PN; Zink, JI | 1 |
| Cristian, L; Farid, RS; Piotrowiak, P | 1 |
| Balsano, E; Berger, W; Göschl, S; Hartinger, CG; Jakupec, MA; Jungwirth, U; Kandioller, W; Keppler, BK; Meier, SM; Roller, A | 1 |
| Barbosa, MI; Barbosa-Filho, JM; Batista, AA; Corrêa, RS; de Oliveira, KM; Ellena, J; Macedo, TS; Nascimento, OR; Nonato, FR; Rocha, VP; Rodrigues, C; Soares, MB | 1 |
| Biersack, B; Mahal, K; Schobert, R; Spoerlein-Guettler, C | 1 |
| Anderson, RF; Hartinger, CG; Jakupec, MA; Kandioller, W; Keppler, BK; Kim, K; Klapproth, E; Kubanik, M; Roller, A; Söhnel, T | 1 |
| Batista, AA; Cominetti, MR; Corrêa, RS; Deflon, VM; Liany, LD; Oliveira, KM | 1 |
| Aissa, AF; Antunes, LMG; Batista, AA; De Grandis, RA; Machado, ART; Oliveira, KM; Pavan, FR; Santos, PWDSD | 1 |
| Batista, AA; Cominetti, MR; Correa, RS; Demidoff, FC; Honorato, J; Netto, CD; Oliveira, KM; Schultz, MS | 1 |
| Batista, AA; Ferreira, NH; Oliveira, KM; Orenha, RP; Parreira, RLT; Ribeiro, AB; Rinaldi-Neto, F; Squarisi, IS; Tavares, DC | 1 |
| Cseh, K; Fuchs, V; Gajic, N; Geisler, H; Harringer, S; Hejl, M; Jakupec, MA; Kandioller, W; Marquetand, P; Plutzar, S; Wenisch, D; Westermayr, J | 1 |
| Chen, NF; Chen, ST; Chen, ZF; Li, YL; Liang, H; Yang, Y; Zhu, XM | 1 |
13 other study(ies) available for ruthenium and naphthoquinones
| Article | Year |
|---|---|
Elimination of broad-host range plasmid vectors in Escherichia coli by curing agents.
Topics: Aminocoumarins; Anti-Bacterial Agents; Cisplatin; Coumarins; Escherichia coli; Genetic Vectors; Naphthoquinones; Plasmids; Ruthenium; Ruthenium Compounds; Santonin; Sodium Dodecyl Sulfate | 1991 |
Placement and characterization of pairs of luminescent molecules in spatially separated regions of nanostructured thin films.
Topics: Cetrimonium; Cetrimonium Compounds; Coumarins; Europium; Hydrophobic and Hydrophilic Interactions; Luminescent Measurements; Micelles; Nanotechnology; Naphthoquinones; Pyrenes; Rhodamines; Ruthenium; Silicates; Silicone Gels; Surface-Active Agents; Terbium | 2002 |
Mimicking photosynthesis in a computationally designed synthetic metalloprotein.
Topics: 2,2'-Dipyridyl; Amino Acid Sequence; Biomimetic Materials; Circular Dichroism; Cytochromes c; Helix-Loop-Helix Motifs; Heme; Metalloproteins; Molecular Sequence Data; Naphthoquinones; Organometallic Compounds; Oxidation-Reduction; Photosynthesis; Photosynthetic Reaction Center Complex Proteins; Protein Conformation; Ruthenium; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2003 |
Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity.
Topics: Amino Acids; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Coordination Complexes; Guanine; Humans; Naphthoquinones; Osmium; Reactive Oxygen Species; Rhodium; Ruthenium | 2013 |
Antiparasitic activities of novel ruthenium/lapachol complexes.
Topics: Animals; Antimalarials; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Leishmania; Mice; Models, Molecular; Molecular Conformation; Naphthoquinones; Plasmodium falciparum; Ruthenium; Trypanocidal Agents | 2014 |
Ferrocene and (arene)ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Coordination Complexes; Cymenes; DNA; Female; Ferrous Compounds; Humans; Metallocenes; Monoterpenes; Naphthoquinones; Ruthenium; Uterine Cervical Neoplasms | 2014 |
Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cymenes; Drug Resistance, Neoplasm; Glutathione; Humans; Monoterpenes; Naphthoquinones; Ruthenium | 2016 |
Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; G1 Phase; Humans; Naphthoquinones; Neoplasms; Ruthenium; S Phase | 2017 |
Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cattle; Cell Line, Tumor; Cell Movement; Coordination Complexes; DNA; Humans; Intercalating Agents; Male; Naphthoquinones; Prostatic Neoplasms; Reactive Oxygen Species; Ruthenium; Spheroids, Cellular | 2019 |
Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; Humans; MCF-7 Cells; Naphthoquinones; Neoplasms; Phosphines; Ruthenium | 2021 |
Anti-melanoma effect of ruthenium(II)-diphosphine complexes containing naphthoquinone ligand.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Ligands; Male; Melanoma; Mice, Inbred C57BL; Naphthoquinones; Phosphines; Ruthenium | 2021 |
Tridentate 3-Substituted Naphthoquinone Ruthenium Arene Complexes: Synthesis, Characterization, Aqueous Behavior, and Theoretical and Biological Studies.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Density Functional Theory; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Naphthoquinones; Ruthenium; Water | 2021 |
Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Coordination Complexes; Energy Metabolism; Humans; Ligands; Mice; Mice, Nude; Naphthoquinones; Ruthenium | 2022 |